NORMALAB BELGIUM

Active

Public limited companyfounded 1998active for 28 yearsRue des Pieds d'Alouette(NN) 28, 5100 Namur, BelgiumKBO/BCE: BE 0462.397.812

From the official registers: KBO 28 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The computed 12-month bankruptcy probability of NORMALAB BELGIUM is 1.8% (moderate). The annual accounts of NORMALAB BELGIUM for financial year 2026 show a net loss of 50% of the equity at the start of that year. The 2026 annual accounts show equity of €126,875 and a net result of -€128,957. Equity is shrinking by about 22% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2028. The company has been active since 1998 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

NORMALAB BELGIUMActiveChecked score 53/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 12-01-1998 Normal situation
Legal form: Public limited company
Registered office: Rue des Pieds d'Alouette(NN) 28, 5100 Namur
Activity: Manufacture of computer, electronic and optical products NACE 26510
Establishment unit: 2.085.145.850 5100 Namur, since 27-01-1998
Financial year end: 31 March
Peppol: Reachable since 01-10-2025

Company details

Who decides

Board

ECREPONT BenoîtDirector · since 26-09-2014
FONTAINE ArmelleDirector · since 26-09-2014

Shareholders

SA ANALISconsolidatesannual accounts 2007

Board & ownership

How it is doing

53 Fair Checked score 2026

Bankruptcy probabilitywithin 12 months: 1.8%

Annual accounts to 31-03-2026

Gross margin: €525,485; ▲ 2.2%
Turnover: ≈ €1.2m; estimated
Loss: €128,957; ▲ 20.3%
Equity: €126,875; ▼ 50.4%
Total assets: €1.2m; ▼ 5.0%
Staff: 8.8 FTE; ▼ 11.1%

2026 accounts 16 days early

Filed on 15-10-2026at the National Bank

Financials

Why 53raises riskLoss of €128,957, the second in a row (financial year 2026)Equity €126,875 (10.3% of total assets)Liquidity: current ratio 0.96, cash €8,602, halvedSize: 8.8 FTE, total assets €1.2mShow the evidence

Checked score

Score 2026

53 / 100

Fair

Probability in this band: 1.5% to 4.2%

Financially better than 16% of its sector peers (NACE 26, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2025

Weak

Solvency 35-10

equity 10.3% of total assets

Liquidity 1-9

short-term debt 89.7% · cash 0.7%

Profitability 6-3

return on assets -10.4%

Bankruptcy probability, 12 months

1.8% Moderate

0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (447 companies, NACE 26, micro)

Last 24 months 11-2024: 1.2% 12-2024: 1.2%● unchanged vs 11-2024 01-2025: 1.2%● unchanged vs 12-2024 02-2025: 1.2%● unchanged vs 01-2025 03-2025: 1.2%● unchanged vs 02-2025 04-2025: 1.2%● unchanged vs 03-2025 05-2025: 1.2%● unchanged vs 04-2025 06-2025: 1.2%● unchanged vs 05-2025 07-2025: 1.3%▲ +0.1 percentage points vs 06-2025 08-2025: 1.3%● unchanged vs 07-2025 09-2025: 1.2%▼ -0.1 percentage points vs 08-2025 10-2025: 1.4%▲ +0.2 percentage points vs 09-2025 11-2025: 0.8%▼ -0.6 percentage points vs 10-2025 12-2025: 0.8%● unchanged vs 11-2025 01-2026: 0.8%● unchanged vs 12-2025 02-2026: 0.8%● unchanged vs 01-2026lowest value 03-2026: 0.8%● unchanged vs 02-2026lowest value 04-2026: 0.8%● unchanged vs 03-2026lowest value 05-2026: 0.8%● unchanged vs 04-2026lowest value 06-2026: 0.8%● unchanged vs 05-2026 07-2026: 0.9%▲ +0.1 percentage points vs 06-2026 08-2026: 0.9%● unchanged vs 07-2026 09-2026: 0.8%▼ -0.1 percentage points vs 08-2026 10-2026: 1.8%▲ +1.0 percentage point vs 09-2026highest value

Credit of up to €6,000 on 30-day terms, only on tighter conditions

Net loss of at least half of total assets or of the equity at the start of the financial year.

Liquidity insufficient (current ratio 0.96, compared with 1.04 in 2025, below 1; short-term debt: 89.7% and cash: 0.7% of total assets), and 89.7% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 26, micro): better than 26% on solvency, 4% on liquidity, 22% on profitability and 12% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

raises riskneutral

Loss of €128,957, the second in a row (financial year 2026)

NBB · annual accounts

Equity €126,875 (10.3% of total assets)

NBB · annual accounts

Liquidity: current ratio 0.96, cash €8,602, halved

NBB · annual accounts

Size: 8.8 FTE, total assets €1.2m

Companies of this size fail more often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Persistent losses

Two consecutive loss-making years (2025 and 2026); equity is also lower. May indicate structural pressure on profitability.

NBB · annual accounts 2026

Net result per financial year

1920212223242526

2019 to 2026 · latest year -€128,957

Latest accounts filed on time

The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 15-10-2026, 16 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2026

16 days early

2025

32 days early

2024

35 days early

2023

on the day

2022

25 days early

2021

59 days late

2020

1 day early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 7 days before the deadline; the sector median (NACE 26) for financial year 2024 is 8 days before the deadline, and 34% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 6 October (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-03-2027 year end31-10-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Risk: 8 loss-making years in a rowloss financial year 2026 -€128,957 View
Caution: Equity fell in 2026from €255,832 to €126,875 ▼ 50.4% View
Positive: Filed on time since financial year 2022accounts within the deadline every year 5 years View

Documents

Key facts about NORMALAB BELGIUM

What is the company number of NORMALAB BELGIUM?: 0462.397.812. In Belgium the VAT number is the company number with BE in front: BE 0462.397.812.
Where is NORMALAB BELGIUM based?: The registered office is at Rue des Pieds d'Alouette(NN) 28, 5100 Namur.Company details
What does NORMALAB BELGIUM do?: According to the KBO register, the main activity is manufacture of computer, electronic and optical products (NACE 26510).
What is the legal form of NORMALAB BELGIUM?: Public limited company (NV).
When was NORMALAB BELGIUM founded?: On 12-01-1998.
Is NORMALAB BELGIUM still active?: Yes, NORMALAB BELGIUM is an active enterprise in the KBO register.
How many employees does NORMALAB BELGIUM have?: On average 8.8 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
What is the turnover of NORMALAB BELGIUM?: ≈ €1.2m in financial year 2026. Estimated from the gross margin of €525,485: probably between €750,000 and €2.1m, based on 2,288 comparable companies of the same size. A rough estimate.
Is NORMALAB BELGIUM profitable?: In financial year 2026, NORMALAB BELGIUM made a loss of €128,957.
Where can I find the annual accounts of NORMALAB BELGIUM?: NORMALAB BELGIUM filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2026.Annual accounts at the National Bank
When are the next annual accounts of NORMALAB BELGIUM due?: By 31-10-2027, for financial year 2027.Timeline